We are live on
!
Find out more
Haemonetics
245 hedge funds and large institutions have $3.58B invested in Haemonetics in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 93 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more capital invested
Capital invested by funds: $3.36B → $3.58B (+$214M)
0.06% more ownership
Funds ownership: 99.49% → 99.55% (+0.06%)
0% less call options, than puts
Call options by funds: $24.2M | Put options by funds: $24.3M
4% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 93
5% less funds holding
Funds holding: 258 → 245 (-13)
24% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 42
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
245
Holders Change
-13
Holders Change %
-5.04%
% of All Funds
4.29%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
32
Increased
89
Reduced
93
Closed
42
Calls
$24.2M
Puts
$24.3M
Net Calls
-$90K
Net Calls Change
+$612K
Top Buyers
| 1 |
BlackRock
New York
|
+$63.8M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$35.5M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$34.9M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$32.3M |
| 5 |
RA
Royce & Associates
New York
|
+$24.2M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$97.5M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$36.3M |
| 3 |
Morgan Stanley
New York
|
-$31.1M |
| 4 |
Renaissance Technologies
New York
|
-$29.7M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$24.6M |
